Susceptibility testing of anaerobic bacteria.
作者信息
Finegold S M
机构信息
Wadsworth Division, Veterans Administration Medical Center, Los Angeles, California 90073.
出版信息
J Clin Microbiol. 1988 Jul;26(7):1253-6. doi: 10.1128/jcm.26.7.1253-1256.1988.
Abstract
摘要
相似文献
1
Susceptibility testing of anaerobic bacteria.厌氧菌的药敏试验。
J Clin Microbiol. 1988 Jul;26(7):1253-6. doi: 10.1128/jcm.26.7.1253-1256.1988.
2
Is there a need for the antibiotic susceptibility testing of anaerobic bacteria?是否有必要对厌氧菌进行抗生素敏感性测试？
Anaerobe. 2015 Feb;31:2-3. doi: 10.1016/j.anaerobe.2014.11.002. Epub 2014 Nov 12.
3
[Infections caused by anaerobes and antibiotic resistance].[厌氧菌引起的感染与抗生素耐药性]
Bol Med Hosp Infant Mex. 1989 Jul;46(7):445-7.
4
Antimicrobial resistance and susceptibility testing of anaerobic bacteria.厌氧菌的抗菌药物耐药性和药敏试验。
Clin Infect Dis. 2014 Sep 1;59(5):698-705. doi: 10.1093/cid/ciu395. Epub 2014 May 27.
5
EUCAST invite comments on new methods for antimicrobial susceptibility testing of anaerobic bacteria.欧洲抗菌药物敏感性试验委员会（EUCAST）邀请就厌氧菌抗菌药物敏感性试验的新方法发表意见。
Anaerobe. 2021 Aug;70:102417. doi: 10.1016/j.anaerobe.2021.102417. Epub 2021 Jul 24.
6
Anaerobic infections--the most important antimicrobial drugs and their clinical profile.厌氧感染——最重要的抗菌药物及其临床概况。
Scand J Gastroenterol Suppl. 1983;85:14-22.
7
Antimicrobial susceptibility patterns of anaerobic bacteria in relation to therapy.厌氧细菌的抗菌药敏模式与治疗的关系
Chemioterapia. 1987 Jun;6(2 Suppl):49-52.
8
Chapter 1-3. Anaerobic infections (general): drug susceptibility tests.第1 - 3章。厌氧感染（概述）：药敏试验。
J Infect Chemother. 2011 Jul;17 Suppl 1:26-30. doi: 10.1007/s10156-010-0133-x.
9
[Standards for microbial sensitivity tests of anaerobic bacteria].[厌氧菌微生物敏感性试验标准]
Rinsho Byori. 1986 Aug;34(8):986-8.
10
Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology.基于临床和实验室标准协会（CLSI）方法学，对2007 - 2009年至2010 - 2012年期间厌氧菌抗生素敏感性的变化进行研究。
Anaerobe. 2016 Dec;42:27-30. doi: 10.1016/j.anaerobe.2016.07.003. Epub 2016 Jul 15.
引用本文的文献
1
In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.脆弱拟杆菌群菌种的体外药敏：分离率的变化显著影响总体药敏数据。
J Clin Microbiol. 2002 Nov;40(11):4349-52. doi: 10.1128/JCM.40.11.4349-4352.2002.
2
Gram-positive anaerobic cocci.革兰氏阳性厌氧球菌
Clin Microbiol Rev. 1998 Jan;11(1):81-120. doi: 10.1128/CMR.11.1.81.
3
Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.导致腹腔内或皮肤/软组织感染治疗临床失败的危险因素。
Eur J Clin Microbiol Infect Dis. 1996 Dec;15(12):913-21. doi: 10.1007/BF01690508.
4
Comparison of spiral gradient endpoint and agar dilution methods for susceptibility testing of anaerobic bacteria: a multilaboratory collaborative evaluation.厌氧细菌药敏试验中螺旋梯度终点法与琼脂稀释法的比较：多实验室协作评估
J Clin Microbiol. 1996 Jan;34(1):170-4. doi: 10.1128/jcm.34.1.170-174.1996.
5
Anaerobic bacteremia: a retrospective four-year analysis in general medicine and cancer patients.厌氧菌血症：对普通内科和癌症患者的四年回顾性分析。
Infection. 1993 Jul-Aug;21(4):241-4. doi: 10.1007/BF01728898.
6
Evaluation of the E test for susceptibility testing of anaerobic bacteria.E试验用于厌氧菌药敏试验的评估。
J Clin Microbiol. 1991 Oct;29(10):2197-203. doi: 10.1128/jcm.29.10.2197-2203.1991.
7
Comparison of spiral gradient and conventional agar dilution for susceptibility testing of anaerobic bacteria.螺旋梯度法与传统琼脂稀释法用于厌氧菌药敏试验的比较。
Antimicrob Agents Chemother. 1991 Jun;35(6):1196-202. doi: 10.1128/AAC.35.6.1196.
8
Anaerobic orbital cellulitis: a clinical and experimental study.厌氧性眼眶蜂窝织炎：一项临床与实验研究。
Trans Am Ophthalmol Soc. 1991;89:313-43; discussion 343-7.
9
Susceptibility testing of anaerobic bacteria: myth, magic, or method?厌氧菌的药敏试验：神话、魔法还是方法？
Clin Microbiol Rev. 1991 Oct;4(4):470-84. doi: 10.1128/CMR.4.4.470.
10
Survey of Bacteroides fragilis group susceptibility patterns in Canada.加拿大脆弱拟杆菌群药敏模式调查。
Antimicrob Agents Chemother. 1992 Feb;36(2):343-7. doi: 10.1128/AAC.36.2.343.
本文引用的文献
1
The clinical significance of clindamycin-resistant Bacteroides fragilis.耐克林霉素脆弱拟杆菌的临床意义。
JAMA. 1982 Oct 15;248(15):1860-1.
2
Intravenous metronidazole for treatment of infections involving anaerobic bacteria.静脉注射甲硝唑用于治疗涉及厌氧菌的感染。
Antimicrob Agents Chemother. 1982 Mar;21(3):441-9. doi: 10.1128/AAC.21.3.441.
3
Antibiotic resistance in anaerobic bacteria: molecular biology and clinical aspects.厌氧菌中的抗生素耐药性：分子生物学与临床方面
Rev Infect Dis. 1982 Nov-Dec;4(6):1075-95. doi: 10.1093/clinids/4.6.1075.
4
Factors affecting the choice of antimicrobial therapy for anaerobic infection.影响厌氧菌感染抗菌治疗选择的因素。
J Antimicrob Chemother. 1982 Aug;10 Suppl A:11-22. doi: 10.1093/jac/10.suppl_a.11.
5
Bacteroides bacteremia. Analysis of 142 episodes from one metropolitan area.拟杆菌属菌血症。来自一个大都市地区的142例病例分析。
Arch Surg. 1984 Aug;119(8):894-8. doi: 10.1001/archsurg.1984.01390200014003.
6
Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.抗生素诱导的脆弱拟杆菌修饰及其对人多形核白细胞吞噬作用的敏感性。
Eur J Clin Microbiol. 1983 Aug;2(4):327-34. doi: 10.1007/BF02019462.
7
Epidemiology and susceptibility of resistant Bacteroides fragilis group organisms to new beta-lactam antibiotics.脆弱拟杆菌群耐药菌的流行病学及对新型β-内酰胺类抗生素的敏感性
Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S254-9. doi: 10.1093/clinids/6.supplement_1.s254.
8
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.美国1292株脆弱拟杆菌属细菌的药敏情况：1981年与1982年的比较
Antimicrob Agents Chemother. 1984 Aug;26(2):145-8. doi: 10.1128/AAC.26.2.145.
9
Anaerobic bacteria and beta-lactam antibiotics.厌氧菌与β-内酰胺类抗生素
Scand J Infect Dis Suppl. 1984;42:72-82.
10
Bacteroides infections.拟杆菌感染
Ann Surg. 1973 May;177(5):601-6.
Zotero 插件